Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor Walsh

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Indian Journal of Thoracic and Cardiovascular Surgery|July 5, 2021
Quadruple valve replacement for patients with carcinoid heart diseaseEleanor Walsh, Rick Steeds, Stephen Rooney, et al.
BMC Infectious Diseases|February 7, 2024
Risk of transmission of SARS-CoV-2 on international flights, a retrospective cohort study using national surveillance data in EnglandJoshua Howkins, Simon Packer, Eleanor Walsh, et al.
RSC Medicinal Chemistry|March 3, 2025
Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregationNadhim Kamil Hante, Aaron P Keogh, Yanni Huang, et al.
Pharmacoeconomics|September 21, 2015
Validation of the Hospital Episode Statistics Outpatient Dataset in EnglandJoanna C Thorn, Emma Turner, Luke Hounsome, et al.
International Journal of Cancer|March 13, 2015
Physical activity, alcohol consumption, BMI and smoking status before and after prostate cancer diagnosis in the ProtecT trial: opportunities for lifestyle modificationLucy E Hackshaw-McGeagh, Chris M Penfold, Eleanor Walsh, et al.
BMJ Open|November 16, 2017
Cross-sectional study evaluating data quality of the National Cancer Registration and Analysis Service (NCRAS) prostate cancer registry data using the Cluster randomised trial of PSA testing for Prostate cancer (CAP)Samuel William David Merriel, Emma L Turner, Eleanor Walsh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 15, 2014
Adherence to dietary and lifestyle recommendations and prostate cancer risk in the prostate testing for cancer and treatment (ProtecT) trialVanessa Er, J Athene Lane, Richard M Martin, et al.
BMJ Open|May 1, 2016
Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)Joanna C Thorn, Emma L Turner, Luke Hounsome, et al.
The Lancet. Oncology|August 29, 2014
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trialJ Athene Lane, Jenny L Donovan, Michael Davis, et al.
Journal of Clinical Epidemiology|June 7, 2019
Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort studyJenny L Donovan, Brent Opmeer, Grace J Young, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Indian Journal of Thoracic and Cardiovascular Surgery|July 5, 2021
Quadruple valve replacement for patients with carcinoid heart diseaseEleanor Walsh, Rick Steeds, Stephen Rooney, et al.
BMC Infectious Diseases|February 7, 2024
Risk of transmission of SARS-CoV-2 on international flights, a retrospective cohort study using national surveillance data in EnglandJoshua Howkins, Simon Packer, Eleanor Walsh, et al.
RSC Medicinal Chemistry|March 3, 2025
Effect of mono-guanidine-like derivatives on platelet aggregation and tumour cell induced platelet aggregationNadhim Kamil Hante, Aaron P Keogh, Yanni Huang, et al.
Pharmacoeconomics|September 21, 2015
Validation of the Hospital Episode Statistics Outpatient Dataset in EnglandJoanna C Thorn, Emma Turner, Luke Hounsome, et al.
International Journal of Cancer|March 13, 2015
Physical activity, alcohol consumption, BMI and smoking status before and after prostate cancer diagnosis in the ProtecT trial: opportunities for lifestyle modificationLucy E Hackshaw-McGeagh, Chris M Penfold, Eleanor Walsh, et al.
BMJ Open|November 16, 2017
Cross-sectional study evaluating data quality of the National Cancer Registration and Analysis Service (NCRAS) prostate cancer registry data using the Cluster randomised trial of PSA testing for Prostate cancer (CAP)Samuel William David Merriel, Emma L Turner, Eleanor Walsh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 15, 2014
Adherence to dietary and lifestyle recommendations and prostate cancer risk in the prostate testing for cancer and treatment (ProtecT) trialVanessa Er, J Athene Lane, Richard M Martin, et al.
BMJ Open|May 1, 2016
Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)Joanna C Thorn, Emma L Turner, Luke Hounsome, et al.
The Lancet. Oncology|August 29, 2014
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trialJ Athene Lane, Jenny L Donovan, Michael Davis, et al.
Journal of Clinical Epidemiology|June 7, 2019
Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort studyJenny L Donovan, Brent Opmeer, Grace J Young, et al.
Pageof 2